(i) development of a high molecular diversity library, made by hemi synthetic compounds, and (ii) screening of this library on dermatological tests, in order to identify new biologically active compounds.
To develop appropriate mixtures of paraffin and iso-paraffin hydrocarbons and stimulants, i.E. To produce a mixture with better quality than wax mixtures used by growers.
Development of a new product line, based on the pyrazolo-triazine motif, enhancing the sirna, aptamers and antisense activities as potential therapeutic tools.
Coated conductors are becoming available in sufficient lengths for insert coils, shieldings and current leads for electro-magnets. The project addresses the technical problems arising from the use of the new material.
The objective is the development of an original, patentable synthesis of the antihypertensive generic drug aliskiren, class renin-angiotensin antagonist. The project result will be the process, leading to the cheap, safe and environmentally friendly production of aliskiren.
We are suggesting to utilise the fruit of autumn olive, which is widely farmed in korea, for the production of natural lycopene. Supercritical co2 extraction, microencapsulation of lycopene, and the development of lycopene formulations for various products will be studied.
A group of considerably less toxic and much easier biodegradable by comparison with the existing ones ionic liquids is foreseen to elaborate and put on production by scientists of the university of latvia, the tallinn university of technology (estonia) and the company bapeks, ltd (latvia).
The project aims to obtain high added value natural ingredients from local plants using sustainable green-technologies. Sharing knowledge in separation technologies, supercritical fluid extraction and molecular distillation, will allow both companies to efficiently use resources to reach this goal
A computer centric method for designing drug-like molecules using fragments will be developed by combining proprietary technology from acellera labs and hql pharmaceuticals. The methodology, will be validated by developing small molecule inhibitors of chemokines, biokine's field of expertise.
The objective is to design optimised reactor for an efficient decontamination of solid waste, containing highly chlorinated pops (persistent organic pollutants) using cdc technology. This technology will be based on an optimized catalytic reaction with copper-based catalyst.